CCEP monthly performance report
View CCEP's monthly returns, drawdown, and seasonality trends — updated every month.
CCEP monthly report
—
Key takeaways
- Coca-Cola Europacific Partners (CCEP) closed November 2026 at $118.57, up 4.73% for the month and +29.37% over the trailing 12 months.
- Year-to-date, CCEP is +30.73%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +16.48% versus its 200-day moving average ($101.79), a bullish technical signal.
- Over the past three years, CCEP has outperformed the S&P 500 by +22.78%, with a relative strength index reading of 113.3.
- Win rate over the trailing 39 months stands at 64.1% — 25 positive months versus 14 negative months.
Coca-Cola Europacific Partners ended November 2026 at $118.57, posting a monthly return of +4.73%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +4.90%.
The current quarter stands at +16.58% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +16.48% versus the 200-day moving average ($101.79).
Year-to-date, CCEP is +30.73% against SPY +10.62%, a gap of +20.10%. The stock is currently −0.44% below its 52-week high, with maximum 3-year drawdown at −19.08%.
| Period | CCEP | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.40% | −0.36% | +1.77% |
| 1 Week | +2.10% | +2.59% | −0.49% |
| 1 Month | +4.73% | −0.18% | +4.90% |
| 3 Months | +10.15% | −2.37% | +12.52% |
| 6 Months | +27.60% | +0.83% | +26.78% |
| YTD | +30.73% | +10.62% | +20.10% |
| 12 Months | +29.37% | +12.25% | +17.12% |
| 3 Years | +94.15% | +71.37% | +22.78% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2026 | +20.43% |
| #2 | Oct 2026 | +11.32% |
| #3 | Jun 2026 | +10.34% |
| #4 | Dec 2023 | +10.06% |
| #5 | Feb 2025 | +9.82% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −17.89% |
| #2 | Aug 2025 | −8.32% |
| #3 | Oct 2023 | −6.35% |
| #4 | Sep 2026 | −5.84% |
| #5 | May 2026 | −4.10% |
| Quarter | Return |
|---|---|
| Q3 2025 | −2.49% |
| Q4 2025 | +0.32% |
| Q1 2026 | −0.03% |
| Q2 2026 | +10.37% |
| Q3 2026 | +1.64% |
| Q4 2026 (QTD) | +16.58% |
| Year | Return |
|---|---|
| 2023 | +20.64% |
| 2024 | +15.09% |
| 2025 | +18.08% |
| 2026 | +30.73% |
| Metric | Value |
|---|---|
| 52-Week High | $119.09 (2026-11-05) |
| 52-Week Low | $84.66 (2026-01-07) |
| Current Price | $118.57 |
| 200-Day Moving Average | $101.79 |
| Price vs 200DMA | +16.48% |
| 3-Year Maximum Drawdown | −19.08% (2026-05-15) |
| Current Drawdown from 52W High | −0.44% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 113.3 |
| 3-Year Excess Return vs S&P 500 | +22.78% |
| RS Peak | 124.1 (Apr 2025) |
| RS Trough | 85.2 (Jun 2026) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was CCEP's return for this report period?
CCEP returned +4.73% in the latest monthly window ending 2026-11-13.
Has CCEP outperformed SPY year to date?
YTD CCEP: +30.73% vs SPY: +10.62%.
What is CCEP's 12-month return?
+29.37% over the trailing 12 months.
Is CCEP above or below its 200-day moving average?
Price is +16.48% versus 200DMA ($101.79).
What is the maximum drawdown in the 3-year window?
−19.08% on 2026-05-15.